Register for our free email digests:
GlaxoSmithKline Inc.
Division of GlaxoSmithKline PLC
www.gsk.ca
Latest From GlaxoSmithKline Inc.
HRSA’s ‘Piecemeal’ Approach To 340B Integrity Rules Draws Manufacturer Objections
Manufacturers say they might be penalized for violating program requirements that are yet to be established, since HRSA is issuing penalties rule first.
GSK Anoro Ellipta Appears Poised For Smooth Advisory Panel; Is First LAMA/LABA On Horizon?
Candidate for first-approved LAMA/LABA combination for COPD heads to the Pulmonary-Allergy Drugs Advisory Committee as FDA questions whether safety is even a concern.
Medtronic Teams Up With Johns Hopkins To Tackle Cardiac Disease In India
Medtronic and Johns Hopkins University’s Center for Bioengineering Innovation and Design are joining forces to develop medical devices for developing countries, starting in India, as part of a Medtronic grant.
Medtronic Teams Up With Johns Hopkins To Tackle Cardiac Disease In India
Medtronic and Johns Hopkins University’s Center for Bioengineering Innovation and Design are joining forces to develop medical devices for developing countries, starting in India, as part of a Medtronic grant.
Company Information
- Industry
-
Pharmaceuticals
- OTC, Consumer
- Vaccines
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Glaxo Canada Ltd.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
Canada
-
Canada
-
North America
- Parent & Subsidiaries
- GlaxoSmithKline PLC
- Senior Management
-
Paul N Lucas, Pres. & CEO
Sav DiPasquale, VP, Bus. Dev. - Contact Info
-
GlaxoSmithKline Inc.
Phone: (905) 819-3000
7333 Mississauga Rd. North
Mississauga, L5N 6L4
Canada
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice